Changes in Glycemic Outcomes Following FreeStyle Libre Initiation Among Individuals with Type 1 Diabetes, Insulin-Intensive Type 2 Diabetes, and Basal Insulin-Treated Type 2 Diabetes: A Retrospective Pre–Post Study in Saudi Arabia
Year: 2026
Type: article
Study design: Observational Study
Abstract: Background/Objectives: Data describing glycemic changes after FreeStyle Libre (FSL) initiation in insulin-treated patients in Saudi Arabia are limited. We compared period-average HbA1c and hospital-recorded acute diabetes events (ADEs) during the 12 months before and after FSL initiation. Methods: This single-center retrospective uncontrolled pre–post cohort included 202 individuals first prescribed FSL between February and July 2023 who had at least three post-initiation sensor dispensing/refill records and no documented discontinuation. The refill criterion selects participants based on follow-up behavior. HbA1c was averaged within each 12-month period. Results: Among 202 participants (70 T1DM, 67 T2DM-MDI, 65 T2DM-Basal), mean HbA1c was 9.1 ± 1.9% before and 8.7 ± 1.8% after initiation (mean within-person change −0.44 percentage points, 95% CI −0.67 to −0.21; paired t-test p < 0.001). Within-group changes were −0.19 (p = 0.318), −0.58 (p = 0.009), and −0.55 (p = 0.008) percentage points in T1DM, T2DM-MDI, and T2DM-Basal, respectively. Between-group differences in change were not significant (ANOVA p = 0.316; Kruskal–Wallis p = 0.137); the common-slope ANCOVA group effect was nonsignificant (F[2, 198] = 1.58, p = 0.208), but the group × baseline HbA1c interaction was significant (F[2, 196] = 4.27, p = 0.015). Exploratory conditional pairwise contrasts at baseline HbA1c levels of 8%, 9% and 10% were not significant after multiplicity adjustment. Exploratory baseline-HbA1c strata were not multiplicity-adjusted and are vulnerable to regression to the mean. ADE counts were sparse. Conclusions: Lower mean HbA1c was observed after FSL initiation among selected patients, particularly in the two T2DM groups within-group; an independent FSL effect cannot be inferred without a comparator or treatment-change information.
Source: Healthcare
Authors: Raed Aldahash(Conceptualization, Methodology, Project administration, Supervision, Validation, Writing – review & editing), Ahmed Alibrahim(Data curation, Investigation, Project administration, Validation, Writing – review & editing), Meshari Al Samih(Investigation, Writing – review & editing), Nawaf Alagrafy(Investigation, Writing – review & editing), Mohammed Alkhalaf(Investigation, Writing – review & editing), Yazeed Alqahtani(Investigation, Writing – review & editing), Saeed Mastour Alshahrani(Conceptualization, Data curation, Formal analysis, Methodology, Validation, Visualization, Writing – review & editing)
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,258
Funder: Abbott Diabetes Care
OpenAlex ID: W7234244671
